Dublin, Oct. 01, 2019 (GLOBE NEWSWIRE) -- The "Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global radiotherapy market is expected to grow at a CAGR of 5.6% from 2019 to reach $10.15 billion by 2025.

The factors such as growing awareness about the benefits of radiotherapy for cancer treatment, increasing incidence & prevalence of cancer, and technological advancements in the field of radiotherapy- are driving the growth of global radiotherapy market. Moreover, opportunities from developing economies and growing government investments for the treatment of cancer further support the growth of this market. However, high cost and complexities associated with the radiotherapy procedures, a paucity of skilled healthcare professionals, and lack of advanced infrastructure facilities hinder the growth of this market.

The overall radiotherapy market is segmented by product (radiotherapy devices, radiotherapy consumables & accessories, software, and services), procedure (external beam radiotherapy and internal beam radiotherapy), technology (external beam radiotherapy (IMRT, IGRT, SRT, 3DCRT, particle therapy, and VMAT), internal beam radiotherapy (high-dose-rate brachytherapy, low-rate brachytherapy, image-guided brachytherapy, pulse-dose rate brachytherapy, intravenous systemic radiotherapy and oral-systemic radiotherapy)), application (prostate, brain, breast, lung, head & neck, colorectal, cervical, and others), end-user (hospitals, independent radiotherapy centers, cancer research institutes), and geography.

Based on product type, radiotherapy devices segment is estimated to command the largest share of the overall radiotherapy market in 2019 and is expected to continue its dominance during the forecast period, mainly due to higher demand for linear accelerators and particle therapy systems with increasing adoption of radiation therapy procedures for the treatment of various types of cancers.

On the basis of end-user, the radiotherapy market for hospitals segment is estimated to command the largest share of the overall radiotherapy market in 2019. This is attributed to the large volume of patient admissions in hospitals for the treatment of cancer and higher affordability of hospitals for high-cost medical devices.

An in-depth analysis of the geographical scenario of the radiotherapy market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to hold the largest share of the overall radiotherapy market in 2019, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The large share of this region is mainly attributed to the well-established healthcare system in the region, greater adoption of advanced healthcare technologies, and the presence of key players.

Key players operating in the global radiotherapy market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C. R. Bard, Inc., Mevion Medical Systems, Inc., Hitachi, Ltd., ViewRay, Inc., Panacea Medical Technologies Pvt. Ltd., Isoray, Inc., Optivus Proton Therapy, Inc., P-Cure, Ltd., Provison Healthcare, LLC, Ion Beam Applications S.A., and Theragenics Corporation.

Key Topics Covered

1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1.1. Secondary Research
2.1.2. Primary Research

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing Awareness About the Benefits of Radiotherapy for Cancer Treatment
4.2.1.2. Increasing Incidence & Prevalence of Cancer
4.2.1.3. Technological Advancements in the Field of Radiotherapy
4.2.2. Restraints
4.2.2.1. High Cost and Complexities Associated with Radiotherapy Procedures
4.2.2.2. Paucity of Skilled Healthcare Professionals
4.2.2.3. Lack of Advanced Infrastructure Facilities
4.2.3. Challenges
4.2.3.1. Difficulties in Visualizing Tumours during Radiotherapy Procedures
4.2.3.2. Risks due to Radiation Exposures
4.2.4. Opportunities
4.2.4.1. Significant Opportunities from Developing Economies
4.2.4.2. Growing Government Investment for Treatment of Cancer

5. Radiotherapy Market, by Procedure
5.1. Introduction
5.2. External Beam Radiotherapy
5.2.1. Linac Based Teletherapy
5.2.2. Proton Therapy
5.2.3. Cobalt-60 Based Teletherapy
5.3. Internal Beam Radiotherapy
5.3.1. Brachytherapy
5.3.2. Systemic Radiotherapy

6. Radiotherapy Market, by Product
6.1. Introduction
6.2. Radiotherapy Devices
6.2.1. External Beam Radiotherapy Systems
6.2.1.1. Conventional Linear Accelerators
6.2.1.2. Conventional Co-60 Teletherapy Units
6.2.1.3. Advanced Stereotactic Radiotherapy Systems
6.2.1.3.1. Gamma Knife
6.2.1.3.2. CyberKnife
6.2.1.3.3. TomoTherapy
6.2.1.4. Proton Therapy Systems
6.2.1.4.1. Cyclotron
6.2.1.4.2. Synchrotron
6.2.1.4.3. Synchrocyclotron
6.2.2. Internal Beam Radiotherapy Systems
6.2.2.1. Brachytherapy Systems
6.2.2.1.1. Electronic Brachytherapy Products
6.2.2.1.2. Afterloaders
6.3. Radiotherapy Consumables and Accessories
6.3.1. Internal Beam Radiotherapy Consumables and Accessories
6.3.1.1. Brachytherapy Consumables & Accessories
6.3.1.1.1. Brachytherapy Applicators
6.3.1.1.2. Brachytherapy Seeds
6.3.1.2. Systemic Radiation Therapy
6.3.1.2.1. Iobenguane (I-131)
6.3.1.2.2. Samarium-153
6.3.1.2.3. Rhenium-186
6.3.1.2.4. Others
6.4. Services
6.5. Software

7. Radiotherapy Market, by Technology
7.1. Introduction
7.2. External Beam Radiotherapy
7.2.1. Intensity-Modulated Radiation Therapy (IMRT)
7.2.2. Image-Guided Radiation Therapy (IGRT)
7.2.3. Stereotactic Radiation Therapy (SRT)
7.2.4. 3D Conformal Radiation Therapy (3D-CRT)
7.2.5. Particle Therapy
7.3. Internal Beam Radiotherapy
7.3.1. Brachytherapy
7.3.1.1. High-Dose Rate Brachytherapy
7.3.1.2. Low-Dose Rate Brachytherapy
7.3.1.3. Image-Guided Brachytherapy
7.3.1.4. Pulse-Dose Rate Brachytherapy
7.3.2. Systemic Radiation Therapy
7.3.2.1. Intravenous Radiotherapy
7.3.2.2. Oral Radiotherapy

8. Radiotherapy Market, by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Prostate Cancer
8.4. Lung Cancer
8.5. Brain Tumour
8.6. Head and Neck Cancer
8.7. Colorectal Cancer
8.8. Cervical Cancer
8.9. Others

9. Radiotherapy Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Independent Radiotherapy Centres
9.4. Cancer Research Institutes

10. Radiotherapy Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. Italy
10.3.4. U.K.
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.6. Middle East & Africa

11. Competitive Landscape
11.1. Competitive Growth Strategies
11.2. Competitive Benchmarking
11.3. Market Share Analysis

12. Company Profiles
12.1. Varian Medical Systems, Inc.
12.1.1. Business Overview
12.1.2. Financial Overview
12.1.3. Product Portfolio
12.1.4. Strategic Developments
12.2. Elekta AB
12.3. Accuray Incorporated
12.4. C. R. Bard, Inc. (A Subsidiary of Becton Dickinson & Company)
12.5. Mevion Medical Systems, Inc.
12.6. Hitachi, Ltd.
12.7. ViewRay, Inc.
12.8. Panacea Medical Technologies Pvt. Ltd.
12.9. IsoRay, Inc.
12.10. Optivus Proton Therapy, Inc.
12.11. P-Cure, Ltd.
12.12. Provision Healthcare, LLC
12.13. Sumitomo Heavy Industries, Ltd.
12.14. Ion Beam Applications S.A.
12.15. Theragenics Corporation

For more information about this report visit https://www.researchandmarkets.com/r/vdibi9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.